Loading company details...
Beta
Latest Form 4 (Aug 5, 2026): Mel Sorensen (President and CEO): Disposition to Issuer of 975 shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Aug 5, 2026 | Mel Sorensen, President and CEO | Disposition to Issuer | 975 | n/a |
| Aug 5, 2026 | Kevin G. Lokay | Disposition to Issuer | 240 | n/a |
| Aug 5, 2026 | Nancy T. Chang | Conversion | 661,309 | n/a |
| Aug 5, 2026 | Lawrence M. Alleva | Disposition to Issuer | 11 | n/a |
| Aug 5, 2026 | Joel F. Sussman, Chief Accounting Officer | Disposition to Issuer | 10,000 | n/a |
| Aug 5, 2026 | Michael R. Friedman | Conversion | 2,989,399 | n/a |
| May 29, 2026 | Emerald Bioventures, LLC | Conversion | 20,813,818 | n/a |
| Apr 9, 2026 | Michael R. Friedman | Conversion | 5,336,870 | n/a |
| Apr 9, 2026 | Nancy T. Chang | Conversion | 1,180,611 | n/a |
| Nov 24, 2025 | Mel Sorensen, President and CEO | Sale | 70,000 | $1.4K |